Once viewed only as power generators, mitochondria are now understood to play a role in mental illness. Their ability to ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with t ...

Parental mental disorders were associated with significant cross-disorder and parent-of-origin patterns of psychiatric risk in offspring.

Stressful situations experienced during adolescence tend to cause deeper and more lasting changes to the brain than those ...

One is a Cochrane review, published in January, that examined the literature on THC efficacy in treating chronic pain — ...

Alto Neuroscience missed the primary endpoint for a study of its ALTO-101 drug for the treatment of cognitive impairment associated with schizophrenia.

New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...

DCF made Larkin its go-to center for seniors' evaluations not long after the FBI linked the hospital to a $1 billion fraud ...

Caring for a friend or loved one with schizophrenia can often feel all-consuming. You may find yourself sacrificing work, ...

Stress in the teen years may have long-term effects on brain function, increasing the risk of mental health disorders later ...

Roluperidone has been de-risked by consistent positive results in two prior pivotal trials and remains the only late-stage drug candidate for ...

Individuals with psychiatric conditions, such as schizophrenia and anxiety, may be predisposed to developing chronic pain conditions.